Developing FKBPL mRNA Therapeutics for Obesity: From Target Biology to In Vivo Proof-of-Concept

• Defining the role of FKBPL in metabolic regulation and its therapeutic potential in obesity
• Addressing mRNA delivery, protein expression and formulation challenges to enable therapeutic development
• Demonstrating preclinical efficacy and outlining the next steps towards translation

Speakers:

Stephanie Annett

Senior Lecturer & Principal Investigator

RCSI University of Medicine and Health Sciences